16:55:37Canada

ProKidney Corp. (PROK)

NASDAQ

Key stats Fiscal year 2025

Income statement

Revenue
893,000 1075%
Net income
-68,986,000
Operating income
-165,007,000
R&D expense
114,123,000

Growth and profitability

Operating margin
-18,477.83
Net margin
-7,725.20
Return on assets
-20.56
Free cash flow margin
-15,152.63

Balance sheet

Total assets
335,574,000
Total liabilities
34,781,000
Shareholders' equity
-1,011,197,000
Cash and equivalents
108,537,000
Current ratio
9.13

Cash flow and ratios

Operating cash flow
-120,117,000
Free cash flow
-135,313,000

Shareholder returns

Share buybacks
0
Revenue and net income
From revenue to profit 2025
Debt, free cash flow and cash

Company information

Headquarters
Winston-Salem, NC
Exchange
NASDAQ
Fiscal year end
12-31
Industry (SEC)
Biological Products, (no Diagnostic Substances)

Fiscal year end: · Source: SEC EDGAR

ProKidney Corp. trades on NASDAQ under the ticker symbol PROK. This page brings together its price chart, company profile, key financial figures and technical indicators.

Company profile

Technical analysis